Stephen J. Freedland , Marty Chakoian , Ted Wells , Nader El-Chaar , Alexandra Colon , Dina Elsouda , Agnes Hong
{"title":"晚期前列腺癌患者的疲劳管理:从对患者的定性访谈中获得的现实世界启示","authors":"Stephen J. Freedland , Marty Chakoian , Ted Wells , Nader El-Chaar , Alexandra Colon , Dina Elsouda , Agnes Hong","doi":"10.1016/j.clgc.2024.102209","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Patients with advanced prostate cancer (PC) commonly experience fatigue related to the disease itself and its treatment, which affects their quality of life. There are limited real-world data available on patients’ experiences of fatigue while receiving PC treatment and its management.</p></div><div><h3>Patients and Methods</h3><p>This was a cross-sectional, noninterventional qualitative study involving individual concept-elicitation interviews with patients in the United States. Patients with advanced PC aged ≥18 years who had experienced fatigue and were on androgen-deprivation therapy in combination with second-generation androgen receptor pathway inhibitors were interviewed and their experiences quantified.</p></div><div><h3>Results</h3><p>Of the 143 patients screened, 13 qualified and 11 completed the interview. Most patients used the term “fatigue” (<em>n</em> = 8) to describe their experiences of tiredness, exhaustion, lack of energy, and weakness. Most patients (<em>n</em> = 8) did not receive any form of educational support from their healthcare providers (HCPs), but some expressed an interest in receiving this support (pamphlets, <em>n</em> = 4; discussion with HCPs, <em>n</em> = 4; online resources, <em>n</em> = 3). Most patients (<em>n</em> = 9) self-discovered fatigue-management strategies over the course of their disease and treatment. Patients found that rigorous exercise (<em>n</em> = 5), regular naps (<em>n</em> = 2), increased rest (<em>n</em> = 3), and a healthy diet (<em>n</em> = 3) were the most effective approaches for managing their fatigue.</p></div><div><h3>Conclusion</h3><p>Tools are needed to support HCPs with counseling patients with PC for effective management of disease- and treatment-related fatigue.</p></div>","PeriodicalId":10380,"journal":{"name":"Clinical genitourinary cancer","volume":"22 6","pages":"Article 102209"},"PeriodicalIF":2.3000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients\",\"authors\":\"Stephen J. Freedland , Marty Chakoian , Ted Wells , Nader El-Chaar , Alexandra Colon , Dina Elsouda , Agnes Hong\",\"doi\":\"10.1016/j.clgc.2024.102209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Patients with advanced prostate cancer (PC) commonly experience fatigue related to the disease itself and its treatment, which affects their quality of life. There are limited real-world data available on patients’ experiences of fatigue while receiving PC treatment and its management.</p></div><div><h3>Patients and Methods</h3><p>This was a cross-sectional, noninterventional qualitative study involving individual concept-elicitation interviews with patients in the United States. Patients with advanced PC aged ≥18 years who had experienced fatigue and were on androgen-deprivation therapy in combination with second-generation androgen receptor pathway inhibitors were interviewed and their experiences quantified.</p></div><div><h3>Results</h3><p>Of the 143 patients screened, 13 qualified and 11 completed the interview. Most patients used the term “fatigue” (<em>n</em> = 8) to describe their experiences of tiredness, exhaustion, lack of energy, and weakness. Most patients (<em>n</em> = 8) did not receive any form of educational support from their healthcare providers (HCPs), but some expressed an interest in receiving this support (pamphlets, <em>n</em> = 4; discussion with HCPs, <em>n</em> = 4; online resources, <em>n</em> = 3). Most patients (<em>n</em> = 9) self-discovered fatigue-management strategies over the course of their disease and treatment. Patients found that rigorous exercise (<em>n</em> = 5), regular naps (<em>n</em> = 2), increased rest (<em>n</em> = 3), and a healthy diet (<em>n</em> = 3) were the most effective approaches for managing their fatigue.</p></div><div><h3>Conclusion</h3><p>Tools are needed to support HCPs with counseling patients with PC for effective management of disease- and treatment-related fatigue.</p></div>\",\"PeriodicalId\":10380,\"journal\":{\"name\":\"Clinical genitourinary cancer\",\"volume\":\"22 6\",\"pages\":\"Article 102209\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical genitourinary cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1558767324001794\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical genitourinary cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1558767324001794","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景晚期前列腺癌(PC)患者通常会感到与疾病本身及其治疗相关的疲劳,这影响了他们的生活质量。关于患者在接受 PC 治疗及其管理过程中的疲劳体验,现有的真实世界数据非常有限。患者和方法这是一项横断面、非介入性的定性研究,对美国患者进行了个人概念诱导访谈。对年龄≥18 岁、接受雄激素剥夺疗法并联合使用第二代雄激素受体通路抑制剂的晚期 PC 患者进行了访谈,并对他们的经历进行了量化。大多数患者使用 "疲劳 "一词(8 人)来描述他们疲倦、精疲力竭、乏力和虚弱的经历。大多数患者(8 人)没有从医疗保健提供者(HCP)那里获得任何形式的教育支持,但有些患者表示有兴趣获得这种支持(小册子,4 人;与 HCP 讨论,4 人;在线资源,3 人)。大多数患者(9 人)在疾病和治疗过程中自我发现了疲劳管理策略。患者发现,剧烈运动(5 例)、定期小睡(2 例)、增加休息(3 例)和健康饮食(3 例)是控制疲劳最有效的方法。
Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients
Background
Patients with advanced prostate cancer (PC) commonly experience fatigue related to the disease itself and its treatment, which affects their quality of life. There are limited real-world data available on patients’ experiences of fatigue while receiving PC treatment and its management.
Patients and Methods
This was a cross-sectional, noninterventional qualitative study involving individual concept-elicitation interviews with patients in the United States. Patients with advanced PC aged ≥18 years who had experienced fatigue and were on androgen-deprivation therapy in combination with second-generation androgen receptor pathway inhibitors were interviewed and their experiences quantified.
Results
Of the 143 patients screened, 13 qualified and 11 completed the interview. Most patients used the term “fatigue” (n = 8) to describe their experiences of tiredness, exhaustion, lack of energy, and weakness. Most patients (n = 8) did not receive any form of educational support from their healthcare providers (HCPs), but some expressed an interest in receiving this support (pamphlets, n = 4; discussion with HCPs, n = 4; online resources, n = 3). Most patients (n = 9) self-discovered fatigue-management strategies over the course of their disease and treatment. Patients found that rigorous exercise (n = 5), regular naps (n = 2), increased rest (n = 3), and a healthy diet (n = 3) were the most effective approaches for managing their fatigue.
Conclusion
Tools are needed to support HCPs with counseling patients with PC for effective management of disease- and treatment-related fatigue.
期刊介绍:
Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.